Treatment with controversial anti-malarial drug hydroxychloroquine may have reduced deaths in hospitalized COVID-19 patients, according to results of a peer-reviewed study by a group of New York researchers. Dr. Takahisa Mikami and his team at Icahn School of Medicine at